Technical events and factor profile →
This 10-Q introduces no material changes to the risk factors vs. the latest annual report.
| Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | |
|---|---|---|---|---|---|
| Revenue | $5.1B | $5.7B | $5.1B | $5.0B | $4.8B |
| YoY growth | +7.4% | +7.1% | +5.8% | +3.5% | +2.7% |
| Gross margin | 38.5% | 39.7% | 38.7% | 39.6% | 42.1% |
| Operating margin | 10.0% | 14.5% | 12.7% | 13.1% | 13.2% |
| Net income | $389M | $588M | $446M | $486M | $564M |
| Diluted EPS | 0.85 | 1.28 | 0.98 | 1.06 | 1.23 |
XBRL data filed with the SEC. The fourth fiscal quarter is calculated as the full year minus the previous three quarters.
0 = the lowest in the universe, 100 = the highest. It describes how the stock has behaved, not whether to buy or sell it. Screen stocks by factors
More optimistic than in the previous 10-Q (2026-04-29: +1, +5 points)
10-Q of 2026-07-29 · 25.5% positive sentences, 17.1% negative · 216 sentences analysed
Index from −100 to +100 calculated with FinBERT on the results discussion (MD&A). The change matters more than the level: some sectors always sound more cautious.
| Trian Fund Management · Nelson Peltz
held since Q3 2023 or earlier |
4.7% | $197.5M | +76194% |
| Bridgewater Associates · Ray Dalio
held since Q1 2024 |
0.0% | $998K | -78% |
Weight in each fund's portfolio and change vs. the previous quarter, from its latest 13F.
All material events for GEHC →
Source: SEC EDGAR. Automatic comparison of the risk factors section; it may contain extraction errors. Always check the original document. For information purposes only; not investment advice.